Product Images Rosuvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 17 images provide visual information about the product associated with Rosuvastatin Calcium NDC 71610-801 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text provides information on cumulative incidence, where the value is 9%. Additionally, it includes details on hazard ratio (HR) which is 0.56 with a 95% confidence interval between 0.46 and 0.68. The p-value is less than 0.001, indicating statistical significance.*
This is data comparing the adverse effects experienced by individuals taking different medications. The table shows the percentage of participants who reported specific side effects such as headache, nausea, fatigue, constipation, and others, for each medication being studied. The results suggest that medication "Adverse" has higher rates of nausea and constipation compared to the placebo, while experiencing less headache. On the other hand, medication "Rasusv:lslalln" shows higher rates of fatigue compared to other medications and placebo.*
This text provides information on adverse reactions associated with the drug Rosuvastatin 40 mg. The data includes the number of patients experiencing various side effects such as myalgia, arthralgia, headache, dizziness, increased C-reactive protein (CPR), abdominal pain, and abnormal liver function tests (>3xULN).*
This is a list of adverse reactions associated with Rosuvastatin 20 mg tablets. Common side effects include myalgia (muscle pain), arthralgia (joint pain), constipation, diabetes mellitus, and nausea. The numbers represent the frequency of each reported side effect.*
This text appears to contain data related to the effects of different doses of Rosuvastatin on various lipid levels and biomarkers. The data shows changes in LDL-C, Non-HDL-C, ApoB, and HDL-C levels at different doses of Rosuvastatin compared to a placebo. The values indicate the impact of each dose on these parameters. This information can be used to understand the efficacy and dose-response relationship of Rosuvastatin in managing cholesterol levels.*
This is a table showing the daily doses of different statin medications. The table includes the medications Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, with varying dose strengths ranging from 10 mg to 80 mg. The values in the table represent the daily dose adjustments for each medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.